Chemoinformaics analysis of 2-(Ethoxymethyl)-3,5-dihydroxypyran-4-one
| Molecular Weight | 186.163 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 7 |
| Exact Molecular Weight | 186.053 | nRing | 1 |
| Solubility: LogS | -1.075 | nHRing | 1 |
| Solubility: LogP | -0.298 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 24.0379 |
| nHD | 2 | BPOL | 14.3721 |
| QED | 0.722 |
| Synth | 3.104 |
| Natural Product Likeliness | 1.273 |
| NR-PPAR-gamma | 0.447 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.008 |
| HIA | 0.012 |
| CACO-2 | -4.616 |
| MDCK | 0.0000174 |
| BBB | 0.051 |
| PPB | 0.720456 |
| VDSS | 0.518 |
| FU | 0.458654 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.397 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.176 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.181 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.081 |
| CL | 7.639 |
| T12 | 0.915 |
| hERG | 0.111 |
| Ames | 0.125 |
| ROA | 0.234 |
| SkinSen | 0.808 |
| Carcinogencity | 0.594 |
| EI | 0.657 |
| Respiratory | 0.128 |
| NR-Aromatase | 0.161 |
| Antiviral | No |
| Prediction | 0.889272 |